Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myeloma

Open access

Abstract

Key Points: We identified CRBN-binding proteins and confirmed recent work implicating the Ikaros transcription factors as important members. Low IZKF1 levels predict lack of IMiD responsiveness and shorter OS; IZKF1 expression is a potential predictive biomarker for clinic application.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2014-02-557819

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Cited by

See all 213

Metadata

Authors
Zhu, Y. X., Braggio, E., Shi, C.-X., Kortuem, K. M., Bruins, L. A., Schmidt, J. E., Chang, X.-B., Langlais, P., Luo, M., Jedlowski, P., LaPlant, B., Laumann, K., Fonseca, R., Bergsagel, P. L., Mikhael, J., Lacy, M., Champion, M. D., & Stewart, A. K.
Affiliations
  • Division of Hematology-Oncology and
  • Mayo Clinic (US)
  • Arizona State University (US)
  • Division of Biomedical Statistics and Informatics and
Venue
Blood
Published
2014-07-24
Volume
124
Issue
4
Pages
536-545
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2055028613
Cited by
213
References
38
Citations by year
2026: 4 · 2025: 10 · 2024: 11 · 2023: 13 · 2022: 26 · 2021: 25 · 2020: 21 · 2019: 22 · 2018: 26 · 2017: 15 · 2016: 17 · 2015: 18 · 2014: 5
FWCI
13.00
Type
journal article
Language
en
Open access
Locations
  • Blood (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Leukemia and Lymphoma Society
  • University of Manchester
  • National Cancer Institute (CA 183968, R01CA183968, P30CA015083)
Topics
  • Health Sciences › Medicine › Hematology › Multiple Myeloma Research and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
Keywords
cereblon, multiple myeloma, immunomodulators, lenalidomide, pomalidomide, IKZF1, IKZF3, KPNA2, lenalidomide resistance, IRF4, treatment response prediction, overall survival, DDB1, CUL4A
MeSH terms
Lenalidomide, Anti-Inflammatory Agents, Carrier Proteins, Dexamethasone, Flow Cytometry, Follow-Up Studies, Humans, Immunologic Factors, Multiple Myeloma, Peptide Hydrolases, Prognosis, Prospective Studies, Thalidomide, Tumor Cells, Cultured, Biomarkers, Tumor, Blotting, Western, Survival Rate, Clinical Trials, Phase II as Topic, Drug Resistance, Neoplasm, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, alpha Karyopherins, Ubiquitin-Protein Ligases, Immunoprecipitation, Adaptor Proteins, Signal Transducing, Ikaros Transcription Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myeloma. https://app.cochat.ai/papers/10.1182/blood-2014-02-557819
The paper
Zhu, Y. X., Braggio, E., Shi, C.-X., Kortuem, K. M., Bruins, L. A., Schmidt, J. E., Chang, X.-B., Langlais, P., Luo, M., Jedlowski, P., LaPlant, B., Laumann, K., Fonseca, R., Bergsagel, P. L., Mikhael, J., Lacy, M., Champion, M. D., & Stewart, A. K. (2014). Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myeloma. Blood. https://doi.org/10.1182/blood-2014-02-557819

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.